ID   PD-iPS2
AC   CVCL_L665
DR   SKIP; SKIP005478
DR   Wikidata; Q54946776
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*11,31; B*35,67 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D12S391: 17,21
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 13.2,15
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 19,20
ST   D7S820: 11,14
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 19,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L664 ! PD-iPS1 [Human iPSC China]
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
RX   PubMed=22673189; DOI=10.1262/jrd.2012-059;
RA   Luo, Yu-Mei
RA   Fan, Yong
RA   Chen, Xin-Jie
RA   Yu, Bo-Lan
RA   Yue, Lei
RA   Wang, Ding
RA   Li, Qing
RA   Chen, Yao-Yong
RA   Sun, Xiao-Fang
RT   "Generation of induced pluripotent stem cells from Asian patients with
RT   chronic neurodegenerative diseases.";
RL   J. Reprod. Dev. 58:515-521(2012).
//